Research Methodology – Cell and Gene Therapy Manufacturing Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Cell and Gene Therapy Manufacturing Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Cell and Gene Therapy Manufacturing Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share:
- Current and projected global/regional market size.
- Number of cell and gene therapy products approved for commercial manufacturing.
- Overall investment in cell and gene therapy manufacturing.
- Total number of players in the market and their respective shares.
- Average price per treatment course.
- Incidence and prevalence of diseases addressed by cell and gene therapies.
- The capacity of manufacturing facilities.
- Growth rate of the cell and gene therapy sector.
- Number of ongoing and upcoming clinical trials for cell and gene therapies.
Key Market Indicators:
- Annual revenue in the cell and gene therapy manufacturing sector.
- Projected growth rate (CAGR) of the market.
- Number of new product approvals by regulatory bodies.
- Distribution of market share among market players.
- Impact of technological advancements on the market.
- Market volatility in terms of raw material prices, production cost, and product pricing.
- Regulatory environment and its changes impacting the market.
Growth Trends:
- Enhanced focus on personalized medicine.
- Increasing number of gene and cell therapies in development pipeline.
- Increased investment in cell and gene therapy production facilities.
- Rising collaborations between pharmaceutical organizations and academic institutes.
- Increased adaptation to automation and digital technology in manufacturing.
- Government support and funding for cell and gene therapy research.
- Advancements in technology such as CRISPR, Dopaminergic Neurons etc.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Cell and Gene Therapy Manufacturing Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Cell and Gene Therapy Manufacturing Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
